Literature DB >> 525358

Blood pressure response to ethanol in relation to acetaldehyde levels and dopamine-beta-hydroxylase activity in rats pretreated with disulfiram, cyanamide and coprine.

O Tottmar, E Hellström.   

Abstract

The blood pressure response after ethanol administration was studied in relation to blood acetaldehyde levels, aldehyde-dehydrogenase (ALDH)--and dopamine-beta-hydroxylase (DBH) activities in rats pretreated with the ethanol-sensitizing compounds disulfiram, cyanamide and coprine and the DBH-inhibitor FLA-57. Disulfiram, cyanamide and coprine, but not FLA-57, inhibited the low-Km ALDH in the liver and caused an increased acetaldehyde level in blood. Disulfiram and FLA-57, but not cyanamide and coprine, decreased the DBH-activity in the heart and the levels of norepinephrine in the heart and the brain. In disulfiram-treated rats with a low DBH-activity, a fall in blood pressure was observed at acetaldehyde levels being slightly higher than those found in control rats. In disulfiram-treated rats with a DBH-activity close to control activity and in rats pretreated with cyanamide or coprine, a fall in blood pressure were observed in rats pretreated with FLA-57. In rats pretreated with coprine + FLA-57, the fall in blood pressure was similar, or even lower, than in rats pretreated with coprine alone. The results suggest that acetaldehyde is the main determinant of the hypotension elicited by ethanol in rats pretreated with ALDH-inhibitors, and that the role of DBH in the disulfiram-ethanol reaction has been over-estimated in previous studies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525358     DOI: 10.1111/j.1600-0773.1979.tb02393.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  6 in total

1.  Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.

Authors:  Angelica R Harper; Anh T Le; Timothy Mather; Anthony Burgett; William Berry; Jody A Summers
Journal:  Bioorg Med Chem       Date:  2018-10-24       Impact factor: 3.641

2.  Aldehyde Dehydrogenase Inhibition Ameliorates Cardiac Dysfunction and Exacerbates Hypotension Caused by Alcohol in Female Rats.

Authors:  Fanrong Yao; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2019-11-24       Impact factor: 3.455

Review 3.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

4.  Differential Effect of Initiating Moderate Red Wine Consumption on 24-h Blood Pressure by Alcohol Dehydrogenase Genotypes: Randomized Trial in Type 2 Diabetes.

Authors:  Yftach Gepner; Yaakov Henkin; Dan Schwarzfuchs; Rachel Golan; Ronen Durst; Ilan Shelef; Ilana Harman-Boehm; Shosana Spitzen; Shula Witkow; Lena Novack; Michael Friger; Osnat Tangi-Rosental; Dana Sefarty; Nitzan Bril; Michal Rein; Noa Cohen; Yoash Chassidim; Benny Sarusi; Talia Wolak; Meir J Stampfer; Assaf Rudich; Iris Shai
Journal:  Am J Hypertens       Date:  2015-08-01       Impact factor: 2.689

5.  Common ALDH2 genetic variants predict development of hypertension in the SAPPHIRe prospective cohort: gene-environmental interaction with alcohol consumption.

Authors:  Yi-Cheng Chang; Yen-Feng Chiu; I-Te Lee; Low-Tone Ho; Yi-Jen Hung; Chao A Hsiung; Thomas Quertermous; Timothy Donlon; Wei-Jei Lee; Po-Chu Lee; Che-Hong Chen; Daria Mochly-Rosen; Lee-Ming Chuang
Journal:  BMC Cardiovasc Disord       Date:  2012-07-29       Impact factor: 2.298

6.  Evaluation of spice and herb as phyto-derived selective modulators of human retinaldehyde dehydrogenases using a simple in vitro method.

Authors:  Thi Bao Chau Bui; Shohei Nosaki; Mito Kokawa; Yuqun Xu; Yutaka Kitamura; Masaru Tanokura; Satoshi Hachimura; Takuya Miyakawa
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.